Cardura recalls
Cardura products have been recalled 2 times, most recently on 22 Jan 2025. The recalling company is usually Viatris. The most common reason is potency & assay.
Total recalls2since 2025
Last 12 months0reported
Class I00% of total
Ongoing0latest 22 Jan 2025
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 2 100%Class III 0 0%
Why cardura is recalled
Companies
Product types
By year
All cardura recalls, newest first
2 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Cardura XL (doxazosin) extended release tablets 4 mg recalled by ViatrisCardura | Viatris | Potency & Assay | Nationwide |
| Drug | CLASS II | Cardura XL (doxazosin) extended release tablets 8 mg recalled by ViatrisCardura | Viatris | Potency & Assay | Nationwide |
About this list
Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.